# Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection

> **NCT02886988** · PHASE2,PHASE3 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 17 (actual)

## Conditions studied

- Scar

## Interventions

- **DRUG:** Botulinum toxin type A
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT02886988
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-12-28
- **Final completion:** 2018-01-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02886988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02886988, "Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02886988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
